|
1
|
Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.
|
J Clin Invest
|
2007
|
3.22
|
|
2
|
Clinical risk factors for portopulmonary hypertension.
|
Hepatology
|
2008
|
2.62
|
|
3
|
Pulmonary vascular complications of liver disease.
|
Am J Respir Crit Care Med
|
2012
|
2.33
|
|
4
|
Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
|
Liver Transpl
|
2007
|
2.13
|
|
5
|
Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
|
J Hepatol
|
2003
|
1.78
|
|
6
|
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.
|
Gastroenterology
|
2010
|
1.60
|
|
7
|
Pulmonary complications in chronic liver disease.
|
Hepatology
|
2014
|
1.57
|
|
8
|
Health-related quality of life and survival in liver transplant candidates.
|
Liver Transpl
|
2010
|
1.55
|
|
9
|
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.
|
Hepatology
|
2003
|
1.46
|
|
10
|
The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
|
Am J Gastroenterol
|
2002
|
1.46
|
|
11
|
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
|
Am J Respir Crit Care Med
|
2009
|
1.44
|
|
12
|
Serial pulse oximetry in hepatopulmonary syndrome.
|
Dig Dis Sci
|
2011
|
1.44
|
|
13
|
Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome.
|
Am J Physiol Lung Cell Mol Physiol
|
2007
|
1.43
|
|
14
|
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
|
Liver Transpl
|
2004
|
1.42
|
|
15
|
The hepatopulmonary syndrome.
|
J Hepatol
|
2006
|
1.37
|
|
16
|
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.
|
Gastroenterology
|
2013
|
1.35
|
|
17
|
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
|
Gastroenterology
|
2008
|
1.23
|
|
18
|
Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
|
Am J Gastroenterol
|
2003
|
1.23
|
|
19
|
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.
|
Hepatology
|
2004
|
1.21
|
|
20
|
Utility of pulse oximetry screening for hepatopulmonary syndrome.
|
Clin Gastroenterol Hepatol
|
2007
|
1.17
|
|
21
|
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.
|
Hepatology
|
2014
|
1.16
|
|
22
|
Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
|
Gastroenterology
|
2003
|
1.16
|
|
23
|
Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38{beta} MAPK-NF-{kappa}B pathway.
|
J Biol Chem
|
2008
|
1.08
|
|
24
|
Hepatopulmonary syndrome.
|
Semin Respir Crit Care Med
|
2012
|
1.08
|
|
25
|
Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.
|
PLoS One
|
2011
|
1.07
|
|
26
|
ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
|
Am J Physiol Gastrointest Liver Physiol
|
2004
|
1.06
|
|
27
|
Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.
|
World J Gastroenterol
|
2005
|
1.05
|
|
28
|
Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
|
J Appl Physiol (1985)
|
2006
|
1.05
|
|
29
|
Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
|
Gastroenterology
|
2005
|
1.05
|
|
30
|
Hepatopulmonary syndrome: update on pathogenesis and clinical features.
|
Nat Rev Gastroenterol Hepatol
|
2012
|
1.05
|
|
31
|
International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
|
Transplantation
|
2016
|
0.99
|
|
32
|
Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates.
|
Liver Transpl
|
2002
|
0.99
|
|
33
|
Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries.
|
Clin Exp Pharmacol Physiol
|
2002
|
0.96
|
|
34
|
Pilot study of pentoxifylline in hepatopulmonary syndrome.
|
Liver Transpl
|
2008
|
0.95
|
|
35
|
Risk of aspiration pneumonia in suspected variceal hemorrhage: the value of prophylactic endotracheal intubation prior to endoscopy.
|
Dig Dis Sci
|
2007
|
0.92
|
|
36
|
Portopulmonary hypertension.
|
Clin Liver Dis
|
2006
|
0.92
|
|
37
|
Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.
|
Gastroenterology
|
2005
|
0.92
|
|
38
|
PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population.
|
Clin Invest Med
|
2012
|
0.91
|
|
39
|
Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: testing the current guidelines.
|
Dig Liver Dis
|
2013
|
0.91
|
|
40
|
The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
|
J Hepatol
|
2012
|
0.91
|
|
41
|
Hepatopulmonary syndrome.
|
Curr Treat Options Gastroenterol
|
2005
|
0.88
|
|
42
|
Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
|
Liver Transpl
|
2006
|
0.87
|
|
43
|
Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
0.87
|
|
44
|
Hepatopulmonary syndrome.
|
Curr Opin Gastroenterol
|
2014
|
0.87
|
|
45
|
Hepatopulmonary syndrome.
|
Clin Liver Dis
|
2005
|
0.86
|
|
46
|
Pulmonary complications in cirrhosis.
|
Curr Opin Organ Transplant
|
2011
|
0.85
|
|
47
|
Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.
|
Cytokine
|
2009
|
0.85
|
|
48
|
Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
|
Am J Gastroenterol
|
2002
|
0.85
|
|
49
|
Hepatopulmonary syndrome: more than just a matter of tone?
|
Hepatology
|
2006
|
0.84
|
|
50
|
Serotonin transporter polymorphisms in patients with portopulmonary hypertension.
|
Chest
|
2009
|
0.83
|
|
51
|
Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules.
|
Clin Gastroenterol Hepatol
|
2013
|
0.82
|
|
52
|
Implementation of vaccination in patients with cirrhosis.
|
Dig Dis Sci
|
2002
|
0.82
|
|
53
|
Hepatopulmonary syndrome.
|
Liver Int
|
2004
|
0.82
|
|
54
|
Pulmonary diseases and the liver.
|
Clin Liver Dis
|
2011
|
0.81
|
|
55
|
Hepatopulmonary syndrome: a good relationship gone bad.
|
Gastroenterology
|
2003
|
0.80
|
|
56
|
Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population.
|
Arch Med Res
|
2012
|
0.80
|
|
57
|
Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
|
J Appl Physiol (1985)
|
2004
|
0.80
|
|
58
|
Gender preference for the endoscopist among Hispanics: the results of a prospective study.
|
J Immigr Minor Health
|
2014
|
0.80
|
|
59
|
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.
|
Liver Transpl
|
2008
|
0.80
|
|
60
|
Plasma levels of S100A4 in portopulmonary hypertension.
|
Biomarkers
|
2009
|
0.79
|
|
61
|
Hepatitis A.
|
Curr Treat Options Gastroenterol
|
2004
|
0.78
|
|
62
|
Portopulmonary hypertension: new clinical insights and more questions on pathogenesis.
|
Hepatology
|
2003
|
0.78
|
|
63
|
Pulmonary complications of cirrhosis.
|
Curr Gastroenterol Rep
|
2011
|
0.78
|
|
64
|
Oxygen desaturation during sleep in hepatopulmonary syndrome.
|
Hepatology
|
2008
|
0.78
|
|
65
|
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
|
World J Gastroenterol
|
2010
|
0.77
|
|
66
|
The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
|
Am J Physiol Gastrointest Liver Physiol
|
2013
|
0.77
|
|
67
|
Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
|
Hepatology
|
2010
|
0.77
|
|
68
|
Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers.
|
Hepatol Int
|
2011
|
0.76
|
|
69
|
Hepatopulmonary syndrome and liver transplantation: who, when, and where?
|
Hepatology
|
2013
|
0.76
|
|
70
|
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation.
|
Liver Transpl
|
2014
|
0.75
|
|
71
|
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study.
|
J Clin Gastroenterol
|
2016
|
0.75
|
|
72
|
Muscle cramps in liver disease.
|
Clin Gastroenterol Hepatol
|
2013
|
0.75
|
|
73
|
Endothelin-B receptor overexpression prevents hypoxic pulmonary hypertension in cirrhotic rats.
|
Chest
|
2005
|
0.75
|
|
74
|
Pulmonary and critical care considerations in hepatic disease.
|
Semin Respir Crit Care Med
|
2012
|
0.75
|